Entry Rationale
LxBio aims to be a global leader in the development and production of advanced therapies based on the application of phages. The company is currently developing several biotechnological solutions that will revolutionise the treatment and prevention of diseases, namely the treatment of diabetic foot infections, respiratory infections and diabetic retinopathy, among others.
Strategy
Support the development of innovative therapies based on the use of phages.